Designing In Vivo T-Cell Therapies to Combat Resistance & Enhance Durability in Solid Tumors
- Identifying mechanisms of resistance to understand impact in vivo CAR-T durability
- Balancing armored CAR/TCR designs to optimize long-term efficacy while minimizing safety risks
- Evaluating in vivo therapeutic approaches for treating solid tumors in complex tumor microenvironments